News-Morimatsu LifeSciences

FROM CRITICAL EQUIPMENT TO
TOTAL PROCESS SOLUTION

BACK

Morimatsu Accompanies Headline Companies to Develop Deep International Cooperation

Morimatsu has recently signed a new order with a leading international vaccine company to undertake process system projects for their new plants in both Asia and Europe. Morimatsu has already undertaken several projects in China carried on by the customer earlier, and this time we participated in th
Magic cleaning Brings Equipment Renewal | Red rust removal service is well received by customers

Red rust mainly refers to various discolorations of stainless steel in pharmaceutical systems, consisting of metal oxides and hydroxides. It mostly occurs in pure steam system, WFI system, purified water system, etc. The Lunar New Year has just passed when the festive atmosp
‘Modular + Digital’ Solution Promotes New Cooperation in Consumer Goods Industry

At the start of year 2022, Morimatsu signed a major project order with an American consumer goods giant to supply superior modular process systems in its new Japanese factory. The undertaking of this project once again proves the strength of Morimatsu in the aspects of process design, outstanding mo
Next-generation vaccines enabled by recombinant protein bioreactors

In the past 2021, Morimatsu has successfully delivered modular factories for COVID-19 vaccines developed via mRNA and adenovirus technology. At the beginning of the new year, we have passed the FAT of the bioreactor system for the recombinant protein enabling COVID-19 vaccines which then are ready f
Use of stainless steel and disposable equipment in biopharmaceutical production

It is well known that the performance of production equipment in the biopharmaceutical industry has a direct impact on product quality and even on the capacity of the entire industry. Stainless steel equipment and disposable equipment are now widely used in biopharmaceutical companies, but wha

Prev ···11 12 13 14 15··· Next